The benefit of minocyline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial (vol 5, pg 885, 2018)
| dc.contributor.author | Deakin, B | |
| dc.contributor.author | Suckling, J | |
| dc.contributor.author | Barnes, TRE | |
| dc.contributor.orcid | Suckling, John [0000-0002-5098-1527] | |
| dc.date.accessioned | 2018-12-20T00:31:53Z | |
| dc.date.available | 2018-12-20T00:31:53Z | |
| dc.date.issued | 2018 | |
| dc.identifier.doi | 10.17863/CAM.34568 | |
| dc.identifier.issn | 2215-0374 | |
| dc.identifier.uri | https://www.repository.cam.ac.uk/handle/1810/287261 | |
| dc.language.iso | eng | |
| dc.title | The benefit of minocyline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial (vol 5, pg 885, 2018) | |
| dc.type | Article | |
| prism.endingPage | E28 | |
| prism.issueIdentifier | 12 | |
| prism.publicationDate | 2018 | |
| prism.publicationName | LANCET PSYCHIATRY | |
| prism.startingPage | E28 | |
| prism.volume | 5 | |
| pubs.funder-project-id | Department of Health (via University of Manchester) (R113428) | |
| pubs.funder-project-id | National Institute for Health Research (NIHR) via Comprehensive Local Research Network (CLRN) (10411) | |
| rioxxterms.licenseref.startdate | 2018-12 | |
| rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
| rioxxterms.type | Journal Article/Review | |
| rioxxterms.version | AM | |
| rioxxterms.versionofrecord | 10.1016/52215-0366(18)30431-0 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Lancet final draft.docx
- Size:
- 475.3 KB
- Format:
- Microsoft Word XML
- Description:
- Accepted version
- Licence
- http://www.rioxx.net/licenses/all-rights-reserved
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- DepositLicenceAgreementv2.1.pdf
- Size:
- 150.9 KB
- Format:
- Adobe Portable Document Format